Industry Analysis: Richmond Research Limited

1. Industry Classification

Richmond Research Limited operates across three distinct SIC classifications: - 26110: Manufacture of electronic components - 72110: Research and experimental development on biotechnology - 72190: Other research and experimental development on natural sciences and engineering

This places the company at the intersection of UK electronic components manufacturing—a subsector of the broader electronics supply chain—and specialist R&D services spanning biotechnology and engineering disciplines. The UK electronic components sector has undergone significant contraction over the past two decades, with domestic manufacturing capacity diminishing as production has migrated to lower-cost jurisdictions in East Asia. The R&D services segment is comparatively more dynamic, supported by government incentives such as R&D tax credits and innovation grants, though it demands sustained capital investment and specialist talent to remain competitive.

Key sector characteristics include: - High capital intensity for active manufacturing operations - Rapid technological obsolescence of plant and equipment - Increasing reliance on intellectual property rather than physical production - Consolidation trends favouring scale operators

2. Relative Performance

Richmond Research Limited's financial metrics fall dramatically below typical industry benchmarks for both electronic components manufacturing and R&D services:

The company's balance sheet has undergone a precipitous decline from approximately £128,000 in total assets (FY2020) to just £360 (FY2024-25)—a reduction exceeding 99.7%. This trajectory is starkly atypical. Even within the micro-entity category, Richmond Research's current position is negligible. The retained P&L reserve of £161 and share capital of £199 together represent the entirety of shareholders' equity, with no turnover figures disclosed (the company having elected to fillet its Profit & Loss Account under Section 444(1) of the Companies Act 2006).

The tangible asset base tells a particularly revealing story: gross cost of £23,755 against accumulated depreciation of £23,694, leaving a net book value of just £61. This indicates the company's plant, machinery, fixtures, and computer equipment are virtually fully depreciated, suggesting these are legacy assets from prior operational activity with no recent reinvestment.

3. Sector Trends Impact

Several industry dynamics contextualise this company's position:

Electronic Components Manufacturing (SIC 26110) - UK domestic production has contracted significantly, with the sector experiencing a long-term structural decline as manufacturing has offshored. The UK Electronics Alliance reports that domestic content in UK electronics has fallen substantially over the past two decades. - Supply chain disruptions post-Brexit and post-pandemic have disproportionately affected smaller operators lacking purchasing power or inventory buffers. - Component miniaturisation and advanced packaging technologies require continuous capital investment that smaller players struggle to sustain.

R&D Services (SIC 72110/72190) - The UK government's commitment to R&D spending (targeting 2.4% of GDP) has supported the sector, with R&D tax credit schemes particularly beneficial for small entities. - However, biotechnology R&D typically requires substantial working capital for laboratory operations, clinical development, and regulatory compliance—none of which are evident in Richmond Research's financial position. - Engineering R&D has shifted toward digital and AI-driven methodologies, requiring investment in computational infrastructure and specialist personnel.

Macro Considerations - Rising interest rates since 2022 have increased the cost of capital for asset-intensive sectors, though this is largely irrelevant given the company's minimal leverage and near-dormant status. - The Dorset local economy, where the company is registered, has a modest manufacturing base with limited sector-specific supply chain infrastructure compared to clusters in the Thames Valley, Cambridge, or the M4 corridor.

4. Competitive Positioning

Assessment: Dormant/Near-Dormant Micro-Entity

Richmond Research Limited does not meaningfully compete within any of its registered industry segments. The evidence points to a company that has substantially ceased trading operations:

• Minimal working capital: £82 cash and £217 in directors' loan accounts (money owed by directors to the company) is insufficient to fund any substantive manufacturing or R&D activity.
• No reinvestment signal: Tangible assets have not been augmented since well before 2024, with depreciation having consumed virtually all asset value.
• Single employee: The sole employee is director Raymond John Peto, indicating the company operates as a personal vehicle rather than a trading enterprise.
• Historical trajectory: The dramatic contraction from £128,018 in total assets (FY2020) to £360 (FY2024-25) suggests either a deliberate extraction of capital, cessation of operations, or both. The most significant drop occurred between FY2020 and FY2021 (from £128,018 to £2,697), coinciding with the pandemic period, though the decline continued thereafter.

Strengths relative to sector norms: - Zero debt and no current liabilities provide a clean, if minimal, balance sheet - Long incorporation history (since 1977) may carry legacy goodwill or intellectual property not reflected on the balance sheet - Dual SIC classification offers theoretical flexibility for future pivoting

Weaknesses relative to sector norms: - Asset base approximately 1,000–10,000x smaller than typical small-sector participants - No visible revenue generation capacity - No investment in plant, equipment, or intellectual property development - Single-person operation with no succession planning evident - Tangible assets are fully depreciated and effectively at end of useful life

The company's current state is more consistent with a dormant or quasi-dormant entity being maintained for administrative purposes rather than as an active market participant. Its competitive positioning is therefore essentially nil within its registered sectors.